Published in Am J Physiol on October 01, 1985
Differential regulation of Na/H antiporter by acid in renal epithelial cells and fibroblasts. J Clin Invest (1991) 1.48
Dietary acid load: a novel nutritional target in chronic kidney disease? Adv Chronic Kidney Dis (2013) 1.15
Hypocitraturia: pathophysiology and medical management. Rev Urol (2009) 1.10
Molecular and functional analysis of SDCT2, a novel rat sodium-dependent dicarboxylate transporter. J Clin Invest (1999) 1.07
Na+/H+ exchangers in renal regulation of acid-base balance. Semin Nephrol (2006) 1.06
Adenosine triphosphate citrate lyase mediates hypocitraturia in rats. J Clin Invest (1996) 0.90
The Na+/H+ exchanger: an update on structure, regulation and cardiac physiology. Biochem J (1993) 0.90
Long-term activation of protein kinase c causes chronic Na/H antiporter stimulation in cultured proximal tubule cells. J Clin Invest (1992) 0.84
Synthesis, maturation, and trafficking of human Na+-dicarboxylate cotransporter NaDC1 requires the chaperone activity of cyclophilin B. J Biol Chem (2011) 0.81
Renal citrate metabolism and urinary citrate excretion in the infant rat. Kidney Int (2000) 0.79
1H NMR-based metabolite profiling of plasma in a rat model of chronic kidney disease. PLoS One (2014) 0.78
Effects of chronic lithium administration on renal acid excretion in humans and rats. Physiol Rep (2014) 0.78
SNPs of metabolism, not stones. Am J Physiol Renal Physiol (2010) 0.75
Expression of Sodium-Dependent Dicarboxylate Transporter 1 (NaDC1/SLC13A2) in Normal and Neoplastic Human Kidney. Am J Physiol Renal Physiol (2016) 0.75
Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney Int (2016) 0.75
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
MedMiner: an Internet text-mining tool for biomedical information, with application to gene expression profiling. Biotechniques (1999) 5.56
EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol (1985) 2.71
Cardio-selective beta-blockade. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 2.33
Molecular evidence that the myxozoan protists are metazoans. Science (1994) 2.29
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med (1972) 2.21
Treatment of primary hyperparathyroidism. Am J Med (1974) 1.98
Primary hyperparathyroidism: a prospective clinical study. Am J Med (1971) 1.93
Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev (1968) 1.88
Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation (1998) 1.74
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
A comparison of ureteroscopy to in situ extracorporeal shock wave lithotripsy for the treatment of distal ureteral calculi. J Urol (1999) 1.57
The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J (1967) 1.54
Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. J Lab Clin Med (1997) 1.52
Cytotoxic efficiency and effect on tumour growth of heterospecific antilymphocytic and antitumour sera. Nature (1970) 1.51
Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47
L-glyceric aciduria. A new genetic variant of primary hyperoxaluria. N Engl J Med (1968) 1.41
beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols. J Med Chem (1977) 1.39
In situ lithotripsy of ureteral calculi: review of 261 cases. Radiology (1990) 1.38
Nicotinate adenine dinucleotide phosphate (NAADP) triggers a specific calcium release system in sea urchin eggs. J Biol Chem (1995) 1.38
The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis (1988) 1.36
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med (1994) 1.36
Disorders of oxalate metabolism. Am J Med (1968) 1.34
Effects of freezing on marrow stem cell suspensions: interactions of cooling and warming rates in the presence of PVP, sucrose, or glycerol. Cryobiology (1970) 1.30
Nicotinate-adenine dinucleotide phosphate-induced Ca(2+)-release does not behave as a Ca(2+)-induced Ca(2+)-release system. Biochem J (1996) 1.29
Government and academic health science centers. West J Med (1993) 1.26
Intussusception: analysis of 98 cases. Br J Surg (1981) 1.25
Clinical features and management of cystinuria. Mayo Clin Proc (1977) 1.25
The in vitro transcription units of bacteriophage phiX174. II. In vitro initiation sites of phiX174 transcription. J Mol Biol (1976) 1.19
Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Intern Med (1972) 1.18
Phosphonocarboxylic acids as specific inhibitors of Na+-dependent transport of phosphate across renal brush border membrane. J Biol Chem (1986) 1.16
Cellular actions of vasopressin in the mammalian kidney. Kidney Int (1976) 1.15
Extranuclear estrogen-regulated destabilization of Xenopus laevis serum albumin mRNA. Mol Endocrinol (1989) 1.15
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidney Int (1996) 1.15
The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol (1983) 1.14
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int (2001) 1.13
Nucleotide sequences of the 5' termini of phi X174 mRNAs synthesized in vitro. Nucleic Acids Res (1974) 1.12
Thyroid cancer in pregnancy. Int J Gynaecol Obstet (2005) 1.10
Endometriosis-related malignancies. Int J Gynecol Cancer (2003) 1.09
Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II. J Clin Invest (1978) 1.08
Effect of histamine and its methyl derivatives on cyclic AMP metabolism in gastric mucosa and its blockade by an H2 receptor antagonist. J Clin Invest (1974) 1.08
Progress with enhancing veterinary surveillance in the United Kingdom. Vet Rec (2007) 1.07
A urinary peptide with extraordinary inhibitory powers against biological "calcification" (deposition of hydroxyapatite crystals). Trans Assoc Am Physicians (1966) 1.07
Anaerobic bacteria in the urinary tract. Mayo Clin Proc (1972) 1.06
Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Invest (1981) 1.06
FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN. J Clin Invest (1948) 1.05
Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest (1985) 1.05
Enzymatic synthesis and degradation of nicotinate adenine dinucleotide phosphate (NAADP), a Ca(2+)-releasing agonist, in rat tissues. Biochem Biophys Res Commun (1995) 1.04
Glucagon-sensitive adenylate cyclase in human renal medulla. J Clin Endocrinol Metab (1976) 1.04
Ca2+ release triggered by nicotinate adenine dinucleotide phosphate in intact sea urchin eggs. Biochem J (1995) 1.03
Effects of demethylchlortetracycline on cellular action of antidiuretic hormone in vitro. Kidney Int (1974) 1.02
Laxative abuse as a cause for ammonium urate renal calculi. J Urol (1990) 1.01
Treatment of primary hyperoxaluria. Mod Treat (1967) 1.01
The in vitro transcription units of bacteriophage phiX174. III. Initiation with specific 5' end oligonucleotides of in vitro phiX174 RNA. J Mol Biol (1976) 1.00
Effect of renal medullary solutes on vasopressin-sensitive adenyl cyclase. Am J Physiol (1972) 1.00
Role of cyclic AMP in the action of neurohypophyseal hormones on kidney. Adv Cyclic Nucleotide Res (1972) 1.00
Potentiation of butylated hydroxytoluene-induced acute lung damage by oxygen. Cell kinetics and collagen metabolism. Am Rev Respir Dis (1983) 0.99
Deficiency of 2-oxo-glutarate: glyoxylate carboligase activity in primary hyperoxaluria. Proc Natl Acad Sci U S A (1967) 0.98
Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acid. Biochem Biophys Res Commun (1986) 0.98
Diazontized (125I) diiodosulafanilic acid as a label for cell surface membranes. Studies on erythrocytes. Biochim Biophys Acta (1979) 0.98
Influence of parathyroid hormone on glomerular ultrafiltration in the rat. Am J Physiol (1978) 0.98
The metabolic error in primary hyperoxaluria. Arch Dis Child (1965) 0.98
Modified nucleosides in urine: selective removal and analysis. Clin Chem (1976) 0.97
Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus. Am J Physiol (1991) 0.97
Parathyroid hormone receptors of renal cortex: specific binding of biologically active, 125I-labeled hormone and relationship to adenylate cyclase activation. Proc Natl Acad Sci U S A (1974) 0.97
ANP inhibits Na(+)-H+ antiport in proximal tubular brush border membrane: role of dopamine. Kidney Int (1990) 0.97
Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol (1975) 0.96
Mechanism of glucocorticoid effect on renal transport of phosphate. Am J Physiol (1982) 0.96
Alan Gregg memorial lecture. Medical education for the 21st century. J Med Educ (1985) 0.96
Epitaxial relationships in urolithiasis: the brushite-whewellite system. Clin Sci Mol Med (1977) 0.96
T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells. Am J Obstet Gynecol (1993) 0.96
Cyclic AMP in action of antidiuretic hormone: effects of exogenous cyclic AMP and its new analogue. Am J Physiol (1977) 0.96
Goniometric reliability for a child with spastic quadriplegia. J Pediatr Orthop (1985) 0.96
ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation. Circ Res (2000) 0.96
Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int (1997) 0.95
Enzymes of cyclic 3',5'-nucleotide metabolism in human renal cortex and renal adenocarcinoma. Kidney Int (1977) 0.95
The determination of pentosans in the analysis of woods: The gravimetric determination of furfuraldehyde. Biochem J (1937) 0.95
Symposium on stones. Introduction. Books in the running brooks, sermons in stone. Am J Med (1968) 0.95
The in vitro transcription units of bacteriophage phiX174. I. Characterization of synthetic parameters and measurement of transcript molecular weights. J Mol Biol (1976) 0.95
Physiological basis of differential strontium accumulation in two barley genotypes. Plant Physiol (1966) 0.95
Hydroxyprolinemia. 3. The origin of free hydroxyproline in hydroxyprolinemia. Collagen turnover. Evidence for biosynthetic pathway in man. Biochim Biophys Acta (1968) 0.94
Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin. J Clin Invest (1982) 0.94
Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab (1980) 0.94
Action of serotonin (5-hydroxytryptamine) on cyclic nucleotides in glomeruli of rat renal cortex. Kidney Int (1979) 0.94
Soft-tissue profile change associated with surgical correction of the prognathic mandible. Am J Orthod (1974) 0.94
Estrogen regulation of Xenopus laevis gamma-fibrinogen gene expression. Biochemistry (1990) 0.94
Cyclic 3',5'-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells. Am J Physiol (1992) 0.94
Beta-adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols. J Med Chem (1968) 0.93
Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases. Am J Med (1991) 0.93
Effects of colchicine and vinblastine on the cellular action of vasopressin in mammalian kidney. A possible role of microtubules. J Clin Invest (1974) 0.93
Cyclic nucleotides in the cellular action of neurohypophyseal hormones. Fed Proc (1977) 0.93
Acquired hyperoxaluria and intestinal disease. Evidence that bile acid glycine is not a precursor of oxalate. Mayo Clin Proc (1973) 0.93
Synthesis of NAADP and cADPR in mitochondria. Arch Biochem Biophys (1999) 0.92
Interaction of lithium with vasopressin-sensitive cyclic AMP system of human renal medulla. Endocrinology (1974) 0.92
Effect of colchicine on urinary phosphate and regulation by parathyroid hormone. Am J Physiol (1976) 0.92
Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci (Lond) (1984) 0.92
Chemical softness and acute metal toxicity in mice and Drosophila. Toxicol Appl Pharmacol (1982) 0.92
Renal adaptation to a low phosphate diet in rats. J Clin Invest (1979) 0.92
Comparison of symptom characteristics of indwelling ureteral catheters. J Urol (1991) 0.92
Percutaneous lithotripsy. J Urol (1983) 0.91